🇮🇹 SAXAGLIPTIN in Italy

SAXAGLIPTIN (SAXAGLIPTIN) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Onglyza
  • Status: approved

SAXAGLIPTIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SAXAGLIPTIN approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for SAXAGLIPTIN in Italy?

Marketing authorisation holder not available in our data.